cetylpyridinium chloride anhydrous has been researched along with guanosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chae, JS; Choi, D; Hyun, YJ; Jang, Y; Kim, BK; Kim, HJ; Kim, OY; Koh, SJ; Lee, JH | 1 |
| Besanko, LK; Burgstad, C; Chapman, MJ; Deane, AM; Fraser, RJ; Holloway, RH; Horowitz, M; Jones, KL; Nguyen, NQ; Rayner, CK; Stevens, JE | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and guanosine
| Article | Year |
|---|---|
Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia.
Topics: Adult; Blood Glucose; Cross-Over Studies; Double-Blind Method; Female; Gastric Emptying; Glucagon-Like Peptide 1; Guanosine; Health; Hormone Antagonists; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Peptide Fragments; Placebos | 2010 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and guanosine
| Article | Year |
|---|---|
Effect of the 252A>G polymorphism of the lymphotoxin-alpha gene on inflammatory markers of response to cigarette smoking in Korean healthy men.
Topics: Adenosine; Adiponectin; Adult; Alleles; Biomarkers; Genotype; Guanosine; Health; Humans; Inflammation Mediators; Lymphotoxin-alpha; Male; Middle Aged; Oxidative Stress; Polymorphism, Genetic; Smoking | 2007 |